Albertsons (ACI) is down about 3% on Tuesday, April 14, 2026 after releasing fiscal fourth-quarter and full-year results and, more importantly for investors, outlining a softer-than-expected fiscal 2026 outlook. The company forecast identical sales growth of flat to +1% for fiscal 2026, below expectations that had been looking for stronger same-store momentum, and guided adjusted EPS to $2.22–$2.32 (midpoint slightly below consensus). (investing.com)

While adjusted profitability topped some expectations, headline results were weighed down by charges tied to opioid-related claims, pushing the quarter to a net loss of $480.8 million versus a profit a year ago. Investors often discount one-time items, but a large GAAP loss alongside a conservative forward view can pressure the stock when the market is already focused on grocery margin durability and demand elasticity. (investing.com)

Albertsons also announced a 13.3% quarterly dividend increase to $0.17 per share (payable May 8, 2026; record date April 24; ex-dividend April 23). Even with the higher payout, today’s trading suggests the market is prioritizing the decelerating growth outlook and competitive pricing pressure over incremental shareholder returns. (streetinsider.com)

The next catalyst is whether management can show stabilization in same-store sales and margins as competitors intensify discounting, while also clarifying how much of the near-term earnings noise is one-time versus structural. Investors will be watching updated fiscal 2026 identical-sales trends, pharmacy headwinds, and any changes to the pace of buybacks or other capital allocation after the guidance reset. (investing.com)